Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Roth

Showing results (781-790 of 839) with videos related to

Pageof 84
Sort By:
Molecular Systems Biology|December 23, 2017
A framework for exhaustively mapping functional missense variantsJochen Weile, Song Sun, Atina G Cote, et al.
Nature Methods|December 9, 2008
An experimentally derived confidence score for binary protein-protein interactionsPascal Braun, Murat Tasan, Matija Dreze, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)Michael P Winters, Darius J Robinson, Hnin Hnin Khine, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Image-based, pooled phenotyping reveals multidimensional, disease-specific variant effectsSriram Pendyala, Katie Partington, Nicholas Bradley, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2023
Pervasive mislocalization of pathogenic coding variants underlying human disordersJessica Lacoste, Marzieh Haghighi, Shahan Haider, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptorPatrick R Maloney, Pasha Khan, Michael Hedrick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2018
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trialH-G Wirsching, G Tabatabai, U Roelcke, et al.
American Journal of Human Genetics|September 20, 2023
Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variationWarren van Loggerenberg, Shahin Sowlati-Hashjin, Jochen Weile, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variationWarren van Loggerenberg, Shahin Sowlati-Hashjin, Jochen Weile, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Comprehensively Testing the Function of Missense Variation in the <i>STK11</i> Tumour SuppressorDaniel Zimmerman, Atina Cote, Warren van Loggerenberg, et al.
Pageof 84

Showing results (781-790 of 839) with videos related to

Sort By:
Pageof 84
Molecular Systems Biology|December 23, 2017
A framework for exhaustively mapping functional missense variantsJochen Weile, Song Sun, Atina G Cote, et al.
Nature Methods|December 9, 2008
An experimentally derived confidence score for binary protein-protein interactionsPascal Braun, Murat Tasan, Matija Dreze, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)Michael P Winters, Darius J Robinson, Hnin Hnin Khine, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Image-based, pooled phenotyping reveals multidimensional, disease-specific variant effectsSriram Pendyala, Katie Partington, Nicholas Bradley, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2023
Pervasive mislocalization of pathogenic coding variants underlying human disordersJessica Lacoste, Marzieh Haghighi, Shahan Haider, et al.
Bioorganic & Medicinal Chemistry Letters|September 27, 2012
Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptorPatrick R Maloney, Pasha Khan, Michael Hedrick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2018
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trialH-G Wirsching, G Tabatabai, U Roelcke, et al.
American Journal of Human Genetics|September 20, 2023
Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variationWarren van Loggerenberg, Shahin Sowlati-Hashjin, Jochen Weile, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Systematically testing human HMBS missense variants to reveal mechanism and pathogenic variationWarren van Loggerenberg, Shahin Sowlati-Hashjin, Jochen Weile, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Comprehensively Testing the Function of Missense Variation in the <i>STK11</i> Tumour SuppressorDaniel Zimmerman, Atina Cote, Warren van Loggerenberg, et al.
Pageof 84